Jeffrey Meyehardt, MD of Harvard Medical School discusses the optimal duration of therapy for patients with stage III colon cancer at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
What is the optimal duration of therapy in stage III colon cancer patients?
